Show simple item record

dc.contributor.authorLund, Michelle
dc.description.abstractCarcinoembryonic Antigen (CEA) is an approved cancer biomarker by the Food and Drug Administration (FDA) for the early detection, diagnosis, and for the use in the regular screening of patients at high risk for the development of cancer. Traditional methods to determine the concentrations of CEA are based on utilizing antibodies. In this project, a graphene oxide (GO)–assisted systematic evolution of ligands through exponential enrichment (SELEX) was used to identify DNA aptamers specific for CEA. The dissociation constants of the identified aptamers were determined with surface plasmon resonance (SPR). Comparison of the dissociation constants of aptamers isolated from the GO-based SELEX and affinity SELEX found the dissociation constant of the aptamers isolated from GO-assisted SELEX was three times lower than aptamers isolated from the affinity SELEX. The analytical applications of the identified aptamers were studied by developing a colorimetric test for the determination of CEA with un-modified gold nanoparticles.en_US
dc.publisherNorth Dakota State Universityen_US
dc.rightsNDSU Policy 190.6.2
dc.titleIdentification of Aptamer Specific for Carcinoembryonic Antigen and its Analytical Applicationsen_US
dc.typeThesisen_US
dc.date.accessioned2018-07-12T20:28:17Z
dc.date.available2018-07-12T20:28:17Z
dc.date.issued2017en_US
dc.identifier.urihttps://hdl.handle.net/10365/28604
dc.identifier.orcid0000-0002-6979-8909
dc.description.sponsorshipNational Institute of Health. Centers for Biomedical Research Excellenceen_US
dc.rights.urihttps://www.ndsu.edu/fileadmin/policy/190.pdf
ndsu.degreeMaster of Science (MS)en_US
ndsu.collegeScience and Mathematicsen_US
ndsu.departmentChemistry and Biochemistryen_US
ndsu.programChemistryen_US
ndsu.advisorLiu, Guodong


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record